Drug:
Reaction: HAEMORRHAGE
20250101 - 20251231
No. 901 - 1000
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 901 | 25038254 |
US |
74 | 1 |
Haemorrhage, |
||||
INSULIN GLARGINE, INSULIN LISPRO, |
||||
| 902 | 25038369 |
US |
79 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 903 | 25038402 |
US |
62 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 904 | 25038445 |
US |
86 | 1 |
Contusion, Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 905 | 25038446 |
US |
67 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 906 | 25038494 |
US |
70 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 907 | 25038754 |
US |
76 | 1 |
Haemorrhage, |
||||
APIXABAN, |
||||
| 908 | 25029001 |
US |
68 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 909 | 25029041 |
US |
||
Haemorrhage, Memory impairment, |
||||
MEPOLIZUMAB, |
||||
| 910 | 25029103 |
US |
80 | 1 |
Anaemia, Haemorrhage, Urinary tract infection, Fatigue, Memory impairment, Off label use, Asthenia, |
||||
LENALIDOMIDE, |
||||
| 911 | 25029204 |
US |
59 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 912 | 25029337 |
US |
93 | 2 |
Haemorrhage, |
||||
LENALIDOMIDE, APIXABAN, CEPHALEXIN, CHOLESTYRAMINE, CARVEDILOL, DULOXETINE HYDROCHLORIDE, FERROUS SULFATE, FOLIC ACID, GABAPENTIN, GLIPIZIDE, ATORVASTATIN CALCIUM, MAGNESIUM OXIDE, NITROGLYCERIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, PROCHLORPERAZINE MALEATE, CHOLESTYRAMINE, MIRTAZAPINE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, LEVOTHYROXINE SODIUM, DULAGLUTIDE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ERGOCALCIFEROL, CETIRIZINE HYDROCHLORIDE, |
||||
| 913 | 25029627 |
PA |
1 | |
Haemorrhage, Varices oesophageal, |
||||
ATEZOLIZUMAB, BEVACIZUMAB, |
||||
| 914 | 25029745 |
US |
50 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 915 | 25029818 |
US |
54 | 2 |
Hypoaesthesia, Haemorrhage, |
||||
THALIDOMIDE, |
||||
| 916 | 25029982 |
CA |
1 | |
Colitis ulcerative, Pain, Haemorrhage, |
||||
VEDOLIZUMAB, PREDNISONE, |
||||
| 917 | 25030043 |
ZA |
1 | |
Traumatic haemorrhage, Haemorrhage, Pain, Insomnia, Depression, Injury, Arthralgia, Pruritus, |
||||
EMICIZUMAB, |
||||
| 918 | 25030100 |
BR |
1 | |
Epilepsy, Cerebrovascular accident, Haemorrhage, Anaemia, Weight increased, Inappropriate schedule of product administration, Asthenia, |
||||
| 919 | 25030461 |
US |
2 | |
Haemorrhage, Dizziness, Fall, Insulin-like growth factor increased, |
||||
DICLOFENAC, DICLOFENAC SODIUM, OCTREOTIDE ACETATE, CELECOXIB, OCTREOTIDE ACETATE, LANREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE, |
||||
| 920 | 25030695 |
HN |
71 | 2 |
Haemorrhage, Meningioma benign, Blood sodium decreased, Syncope, Fall, Head injury, Gait disturbance, |
||||
| 921 | 25030760 |
US |
1 | |
Haemorrhage, |
||||
| 922 | 25030805 |
US |
79 | 1 |
Haemorrhage, Off label use, |
||||
APIXABAN, APIXABAN, |
||||
| 923 | 25030872 |
US |
86 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 924 | 25031055 |
61 | ||
Epistaxis, Haemorrhage, Off label use, |
||||
RUXOLITINIB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ASCORBIC ACID, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE, MOMETASONE FUROATE, MONTELUKAST SODIUM, TETRACAINE, CALCIUM CARBONATE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, CETIRIZINE HYDROCHLORIDE, |
||||
| 925 | 25031383 |
US |
53 | 1 |
Haemorrhage, Animal scratch, |
||||
| 926 | 25031488 |
VN |
||
Haemorrhage, Off label use, |
||||
CYCLOSPORINE, ELTROMBOPAG, |
||||
| 927 | 25032044 |
US |
1 | |
Haemorrhage, |
||||
EMICIZUMAB, EMICIZUMAB, |
||||
| 928 | 25032067 |
US |
1 | |
Haemorrhage, |
||||
EMICIZUMAB, |
||||
| 929 | 25032069 |
US |
19 | 1 |
Haemorrhage, |
||||
EMICIZUMAB, EMICIZUMAB, EMICIZUMAB, |
||||
| 930 | 25032174 |
GB |
22 | 2 |
Haematochezia, Balance disorder, Groin pain, Flatulence, Delusion, Urinary tract infection, Candida infection, Constipation, Anal haemorrhage, Haemorrhage, Heavy menstrual bleeding, Fatigue, |
||||
CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, |
||||
| 931 | 25032315 |
MX |
18 | 1 |
Blood urine present, Thrombosis, Haemorrhage, Contusion, Pain in extremity, Product use issue, Incorrect dose administered, Product administration interrupted, Product supply issue, Inflammation, Oedema peripheral, Arthritis, |
||||
| 932 | 25032563 |
VN |
||
Haemorrhage, Off label use, |
||||
CYCLOSPORINE, |
||||
| 933 | 25032663 |
JP |
8 | |
Immune-mediated enterocolitis, Haematochezia, Gastrooesophageal reflux disease, Haemorrhage, |
||||
DURVALUMAB, DURVALUMAB, TREMELIMUMAB, TREMELIMUMAB, |
||||
| 934 | 25032695 |
US |
10 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 935 | 25032697 |
US |
68 | 1 |
Haemorrhage, Pain, Discomfort, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 936 | 25032698 |
US |
72 | 2 |
Haemorrhage, Contusion, |
||||
INSULIN LISPRO, |
||||
| 937 | 25032794 |
BR |
2 | |
Fear of death, Haemorrhage, Platelet count decreased, Vaginal haemorrhage, Thrombocytopenia, Drug dependence, Depressed mood, Malaise, Dengue fever, Crying, Depression, Product dose omission issue, Product dose omission issue, Product dose omission issue, Hormone level abnormal, Arthralgia, Influenza, Immune system disorder, Pyrexia, Varicose vein, Haematoma, Petechiae, Stress, |
||||
ELTROMBOPAG OLAMINE, ELTROMBOPAG OLAMINE, ELTROMBOPAG OLAMINE, LOSARTAN, HYDROCHLOROTHIAZIDE, TOPIRAMATE, TOPIRAMATE SPINKLE, ORLISTAT, ERGOCALCIFEROL, |
||||
| 938 | 25033378 |
US |
31 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, HUMAN INSULIN, |
||||
| 939 | 25033405 |
US |
66 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, INSULIN ASPART, |
||||
| 940 | 25033765 |
US |
63 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 941 | 25033982 |
US |
1 | |
Haemorrhage, Haemoglobin decreased, |
||||
EMICIZUMAB, |
||||
| 942 | 25033991 |
US |
5 | 1 |
Haemorrhage, |
||||
EMICIZUMAB, |
||||
| 943 | 25034010 |
ZA |
8 | 1 |
Haemorrhage, |
||||
EMICIZUMAB, |
||||
| 944 | 25028635 |
US |
1 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, ERLOTINIB HYDROCHLORIDE, |
||||
| 945 | 25028681 |
US |
51 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 946 | 25028690 |
US |
45 | 1 |
Haemorrhage, Haemorrhage, Haemorrhage, |
||||
| 947 | 25028691 |
US |
28 | 1 |
Haemorrhage, Haemarthrosis, |
||||
EMICIZUMAB, |
||||
| 948 | 25028745 |
US |
66 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 949 | 25028750 |
US |
80 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN DEGLUDEC, |
||||
| 950 | 25028754 |
US |
85 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 951 | 25028769 |
US |
57 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 952 | 25028786 |
US |
2 | |
Haemorrhage, Confusional state, |
||||
ADALIMUMAB, |
||||
| 953 | 25028951 |
US |
22 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 954 | 25031758 |
40 | 2 | |
Haemorrhage, |
||||
TRASTUZUMAB, |
||||
| 955 | 25025765 |
US |
83 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 956 | 25025909 |
US |
2 | |
Haemorrhage, Drug ineffective, |
||||
LIRAGLUTIDE, |
||||
| 957 | 25026202 |
US |
75 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 958 | 25026265 |
US |
17 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 959 | 25026342 |
US |
90 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 960 | 25026399 |
US |
72 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 961 | 25026452 |
US |
21 | 2 |
Haemorrhage, |
||||
INSULIN GLARGINE, INSULIN LISPRO, |
||||
| 962 | 25026566 |
US |
65 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 963 | 25026572 |
US |
79 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN DEGLUDEC, |
||||
| 964 | 25026583 |
US |
66 | 2 |
Contusion, Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 965 | 25026589 |
US |
82 | 2 |
Haemorrhage, |
||||
INSULIN GLARGINE, INSULIN ASPART INJECTION, INSULIN ASPART, |
||||
| 966 | 25026591 |
US |
5 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 967 | 25026595 |
US |
81 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 968 | 25026622 |
US |
75 | 1 |
Haemorrhage, Pain, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 969 | 25026627 |
US |
71 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 970 | 25026628 |
US |
81 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 971 | 25026633 |
US |
83 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 972 | 25026635 |
US |
67 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 973 | 25026643 |
US |
79 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 974 | 25026644 |
US |
45 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, SEMAGLUTIDE, |
||||
| 975 | 25026693 |
US |
1 | |
Haemorrhage, |
||||
ANTIHEMOPHILIC FACTOR (RECOMBINANT), FC-VWF-XTEN FUSION PROTEIN-EHTL, |
||||
| 976 | 25026733 |
US |
61 | 1 |
Haemorrhage, |
||||
| 977 | 25026797 |
US |
16 | 1 |
Anti factor VIII antibody positive, Influenza, Respiratory tract congestion, Cough, Fatigue, Haemorrhage, Ecchymosis, Peripheral swelling, Contusion, Soft tissue haemorrhage, Joint swelling, |
||||
ANTIHEMOPHILIC FACTOR (RECOMBINANT), FC-VWF-XTEN FUSION PROTEIN-EHTL, |
||||
| 978 | 25027187 |
US |
31 | 1 |
Pruritus, Sleep disorder, Dry skin, Skin exfoliation, Haemorrhage, Skin weeping, Treatment failure, |
||||
DUPILUMAB, |
||||
| 979 | 25027269 |
US |
46 | 1 |
Haemorrhage, Dry skin, Drug ineffective, |
||||
DUPILUMAB, |
||||
| 980 | 25027660 |
US |
21 | 1 |
Haemorrhage, Limb injury, |
||||
ANTIHEMOPHILIC FACTOR (RECOMBINANT), FC-VWF-XTEN FUSION PROTEIN-EHTL, |
||||
| 981 | 25027745 |
US |
50 | 1 |
Limb injury, Haemorrhage, |
||||
| 982 | 25028318 |
US |
47 | 1 |
Haemorrhage, |
||||
| 983 | 25028391 |
US |
64 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 984 | 25028392 |
US |
70 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 985 | 25021720 |
US |
4 | 1 |
Haemorrhage, Fall, Mass, Infusion site swelling, Head injury, Fall, Head injury, |
||||
AMINOCAPROIC ACID, |
||||
| 986 | 25021852 |
JP |
90 | 1 |
Acute myeloid leukaemia, Haemorrhage, |
||||
BORTEZOMIB FOR INJECTION, BORTEZOMIB, DARATUMUMAB, DARATUMUMAB, DARATUMUMAB, DARATUMUMAB, DARATUMUMAB, DARATUMUMAB, DARATUMUMAB, DARATUMUMAB, DARATUMUMAB, DARATUMUMAB, MELPHALAN, FUROSEMIDE, VENETOCLAX, VENETOCLAX, AZACITIDINE, |
||||
| 987 | 25022023 |
US |
1 | |
Haemorrhage, Inappropriate schedule of product administration, |
||||
| 988 | 25022042 |
JP |
14 | 1 |
Haemorrhage, Haemorrhage subcutaneous, |
||||
| 989 | 25022094 |
US |
32 | 2 |
Haemorrhage, Vaginal haemorrhage, Maternal exposure during pregnancy, |
||||
SEMAGLUTIDE, SEMAGLUTIDE, |
||||
| 990 | 25022117 |
JP |
84 | |
Rheumatoid arthritis, Synovitis, Haemorrhage, |
||||
DURVALUMAB, |
||||
| 991 | 25022373 |
US |
45 | 2 |
Haemorrhage, Epistaxis, |
||||
| 992 | 25022389 |
CO |
24 | 1 |
Haemorrhage, Drug ineffective, Product availability issue, Product dose omission issue, Arthritis, |
||||
| 993 | 25022918 |
JP |
2 | |
Haemorrhage, Muscular weakness, Fracture, Rheumatic disorder, Condition aggravated, Wrong technique in device usage process, Tremor, Fatigue, |
||||
ABATACEPT, |
||||
| 994 | 25023684 |
US |
1 | |
Accident at work, Haemorrhage, |
||||
| 995 | 25024068 |
78 | 1 | |
Iron deficiency anaemia, Haemorrhoids, Haemorrhage, |
||||
APIXABAN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 996 | 25024069 |
59 | 1 | |
Haemorrhage, |
||||
WARFARIN SODIUM, WARFARIN, |
||||
| 997 | 25024230 |
89 | 1 | |
Anaemia, Haemorrhage, Therapy cessation, |
||||
APIXABAN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 998 | 25024261 |
JP |
12 | 1 |
Haemorrhage, |
||||
EMICIZUMAB, EMICIZUMAB, |
||||
| 999 | 25024428 |
83 | 1 | |
Haemoptysis, Incorrect dose administered, Haemorrhage, |
||||
APIXABAN, |
||||
| 1000 | 25024505 |
CA |
3 | 1 |
Abdominal discomfort, Arthralgia, Asthenia, Diarrhoea, Drug ineffective, Epistaxis, Fatigue, Haemorrhage, Irritability, Mood altered, Platelet count increased, Wrist fracture, Contusion, Petechiae, Therapy non-responder, Traumatic haemorrhage, Product use in unapproved indication, Off label use, Off label use, |
||||
RITUXIMAB, ELTROMBOPAG OLAMINE, ELTROMBOPAG OLAMINE, ELTROMBOPAG OLAMINE, ELTROMBOPAG OLAMINE, ELTROMBOPAG OLAMINE, METHYLPREDNISOLONE ACETATE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28